<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
	"http://www.w3.org/TR/1998/REC-html40-19980424/loose.dtd">
<html>
<head><meta http-equiv="content-type" content="text/html; charset=UTF-8">
<style type="text/css">
 table.main {}
 tr.row {}
 td.cell {}
 div.block {}
 div.paragraph {}
 .font0 { font:6pt Arial, sans-serif; }
 .font1 { font:7pt Arial, sans-serif; }
 .font2 { font:8pt Arial, sans-serif; }
 .font3 { font:9pt Arial, sans-serif; }
 .font4 { font:12pt Arial, sans-serif; }
 .font5 { font:14pt Arial, sans-serif; }
 .font6 { font:10pt Times New Roman, serif; }
 .font7 { font:11pt Times New Roman, serif; }
 .font8 { font:18pt Times New Roman, serif; }

</style>
</head>
<body>
<p><span class="font5">This document is being provided for the exclusive use of PORTFOLIO MANAGEMENT CLUB at UNIVERSIDADE NOVA DE LISBOA.</span></p>
<div>
<p><span class="font1">Richard Vosser</span></p>
<p><span class="font1">(44-20) 7742-6652</span></p>
<p><span class="font1">richard. vosser@jpmorgan .com</span></p>
</div><br clear="all">
<div>
<p><span class="font1" style="font-weight:bold;">Europe Equity Research</span></p>
<p><span class="font1">24 February 2023</span></p>
</div><br clear="all">
<div>
<p><span class="font8">J.P. Morgan</span></p>
</div><br clear="all">
<p><span class="font6" style="font-weight:bold;">Analyst Certification: </span><span class="font6">The Research Analyst(s) denoted by an “AC” on the cover of this report certifies Con where multiple Research Analysts are primarily responsible for this report, the Research Analyst denoted by an “AC” on the cover or within the document individually certifies, with respect to each security or issuer that the Research Analyst covers in this research) that: (1) all of the views expressed in this report accurately reflect the Research Analyst’s personal views about any and all of the subject securities or issuers; and (2) no part of any of the Research Analyst's compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed by the Research Analyst(s) in this report. For all Korea-based Research Analysts listed on the front cover, if applicable, they also certify, as per KOFI A requirements, that the Research Analyst’s analysis was made in good faith and that the views reflect the Research Analyst’s own opinion, without undue influence or intervention.</span></p>
<p><span class="font6">All authors named within this report are Research Analysts who produce independent research unless otherwise specified. In Europe, Sector Specialists (Sales and Trading) may be shown on this report as contacts but are not authors of the report or part of the Research Department.</span></p>
<p><span class="font7" style="font-weight:bold;">Important Disclosures</span></p>
<p><span class="font6" style="font-weight:bold;">. Market Maker/ Liquidity Provider: </span><span class="font6">J.P. Morgan is a market maker and/or liquidity provider in the financial instruments of related to Sanofi.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font6" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Client: </span><span class="font6">J.P. Morgan currently has, or had within the past 12 months, the following entity(ies) as clients: Sanofi.</span></p></li>
<li>
<p><span class="font6" style="font-weight:bold;">. &nbsp;&nbsp;&nbsp;ClienVInvestment Banking: </span><span class="font6">J.P. Morgan currently has, or had within the past 12 months, the following entity(ies) as investment banking clients: Sanofi.</span></p></li>
<li>
<p><span class="font6" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Client/Non-Investment Banking, Securities-Related: </span><span class="font6">J.P. Morgan currently has, or had within the past 12 months, the following entity(ies) as clients, and the sendees provided were non-investment-banking, securities-related: Sanofi.</span></p></li>
<li>
<p><span class="font6" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Client/Non-Secur¡ties-Related: </span><span class="font6">J.P. Morgan currently has, or had within the past 12 months, the following entity(ies) as clients, and the sendees provided were non-securities-related: Sanofi.</span></p></li>
<li>
<p><span class="font6" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Investment Banking Compensation Received: </span><span class="font6">J.P. Morgan has received in the past 12 months compensation for investment banking sendees from Sanofi.</span></p></li>
<li>
<p><span class="font6" style="font-weight:bold;">. &nbsp;&nbsp;&nbsp;Potential Investment Banking Compensation: </span><span class="font6">J.P. Morgan expects to receive, or intends to seek, compensation for investment banking sendees in the next three months from Sanofi.</span></p></li>
<li>
<p><span class="font6" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Non-Investment Banking Compensation Received: </span><span class="font6">J.P. Morgan has received compensation in the past 12 months for products or services other than investment banking from Sanofi.</span></p></li>
<li>
<p><span class="font6" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Debt Position: </span><span class="font6">J.P. Morgan may hold a position in the debt securities of Sanofi, if any.</span></p></li></ul>
<p><span class="font6" style="font-weight:bold;">Company-Specific Disclosures: </span><span class="font6">Important disclosures, including price charts and credit opinion history tables, are available for compendium reports and all J.P. Morgan-covered companies, and certain non-covered companies, by visiting</span><a href="https://www.ipmm.coin/research/disclosures"><span class="font6" style="text-decoration:underline;">https://www.ipmm.coin/research/disclosures</span></a><span class="font6" style="text-decoration:underline;">, </span><span class="font6">calling 1 -800-477-0406, or e-mailing </span><a href="mailto:research.disclosure.inquiries@ipmorgan.com"><span class="font6" style="text-decoration:underline;">research.disclosure.inquiries@ipmorgan.com</span></a><span class="font6"> with your request.</span></p>
<div>
<p><span class="font2">Sanofi (SASY.PA, SAN FP) Price Chart</span></p>
</div><br clear="all">
<div>
<p><span class="font1">150</span></p>
<p><span class="font1">140</span></p>
<p><span class="font1">130</span></p>
<p><span class="font1">120</span></p>
<p><span class="font1">110</span></p>
<p><span class="font3">Price(€)</span></p>
<p><span class="font1">100</span></p>
<p><span class="font1">90</span></p>
<p><span class="font1">80</span></p>
<p><span class="font1">70</span></p>
<p><span class="font1">60</span></p>
</div><br clear="all">
<div>
<p><span class="font0" style="font-weight:bold;">ow</span></p>
</div><br clear="all">
<div>
<p><span class="font0" style="font-weight:bold;text-decoration:underline;">€93]</span></p>
</div><br clear="all">
<div>
<p><span class="font0" style="font-weight:bold;">]OW €115 I</span></p>
</div><br clear="all">
<div>
</div><br clear="all">
<div>
<p><span class="font0" style="font-weight:bold;">|0W€1Q5|</span></p>
<table border="1">
<tr><td style="vertical-align:top;">
<p><span class="font1" style="font-weight:bold;">Date</span></p></td><td style="vertical-align:top;">
<p><span class="font1" style="font-weight:bold;">Rating</span></p></td><td style="vertical-align:top;">
<p><span class="font1" style="font-weight:bold;">Price (€)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">Price Target</span></p>
<p><span class="font1" style="font-weight:bold;">(€)</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font1">31-Jul-20</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">OW</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1">88.55</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1">106</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font1">30-0ct-20</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">OW</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1">78.23</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1">100</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font1">04-Jan-21</span></p></td><td style="vertical-align:top;">
<p><span class="font4">ow</span></p></td><td style="vertical-align:top;">
<p><span class="font1">78.70</span></p></td><td style="vertical-align:top;">
<p><span class="font1">93</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font1">30-Jul-21</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">ow</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1">86.52</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1">100</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font1">14-Oct-21</span></p></td><td style="vertical-align:top;">
<p><span class="font4">ow</span></p></td><td style="vertical-align:top;">
<p><span class="font1">83.53</span></p></td><td style="vertical-align:top;">
<p><span class="font1">105</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font1">29-Jul-22</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">ow</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1">98.60</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1">115</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font1">30-NOV-22</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">NR</span></p></td><td style="vertical-align:middle;">
<p><span class="font1">88.19</span></p></td><td style="vertical-align:middle;">
<p><span class="font1">-</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font1">03-Jan-23</span></p></td><td style="vertical-align:top;">
<p><span class="font4">OW</span></p></td><td style="vertical-align:top;">
<p><span class="font1">91.68</span></p></td><td style="vertical-align:top;">
<p><span class="font1">105</span></p></td></tr>
</table>
</div><br clear="all">
<p><span class="font1">Source: Bloomberg Finance L.P. and J.P. Morgan; price data adjusted for stock splits and dividends.</span></p>
<p><span class="font1">Initiated coverage Dec 11, 2000. All share prices are as of market close on the previous business day.</span></p>
<p><span class="font6">The chart(s) show J.P. Morgan's continuing coverage of the stocks; the current analysts may or may not have covered it over the entire period. J.P. Morgan ratings or designations: OW = Overweight, N= Neutral, UW = Underweight, NR = Not Rated</span></p>
<p><span class="font2">3</span></p>
</body>
</html>